tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gil Blum, 485 are a BUY (98.58%), 4 are a HOLD (0.81%), 3 are a SELL (0.61%).
Analyst Gil Blum, currently employed at NEEDHAM, carries an average stock price target met ratio of 31.17% that have a potential upside of 68.69% achieved within 142 days.
Gil Blum’s has documented 895 price targets and ratings displayed on 31 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NRIX, Nurix Therapeutics at 10-Jul-2026.
Analyst best performing recommendations are on ABSI (ABSCI CORP).
The best stock recommendation documented was for CELC (CELCUITY LLC) at 6/30/2025. The price target of $29 was fulfilled within 28 days with a profit of $15.65 (117.23%) receiving and performance score of 41.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
$24
$22.6 (1614.29%)
$60
2 years 7 months 12 days ago
(18-Dec-2023)
0/5 (0%)
$24 (0.00%)
$2
$0.6 (42.86%)
$36
3 years 17 days ago
(13-Jul-2023)
0/3 (0%)
$2 (0.00%)
$2
$0.6 (42.86%)
$14
3 years 18 days ago
(12-Jul-2023)
0/4 (0%)
$2 (0.00%)
$6
$4.6 (328.57%)
$6
3 years 4 months 6 days ago
(24-Mar-2023)
0/5 (0%)
$6 (0.00%)
Hold Since 08-Dec-2022
$4
3 years 7 months 22 days ago
(08-Dec-2022)
0/3 (0%)
$4 (0.00%)
Which stock is Gil Blum is most bullish on?
Which stock is Gil Blum is most reserved on?
What Year was the first public recommendation made by Gil Blum?
